BriaCell Therapeutics Corp. (BCTX) earnings
Quarterly results of BriaCell Therapeutics Corp. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
BriaCell Therapeutics Corp. was expected to report around October 15, 2026; nothing is on file with the SEC yet.
Latest quarter: Q3 FY2026
In Q3 FY2026 (ended April 30, 2026) BriaCell Therapeutics Corp. reported revenue of - and a net loss of $7.2M.
Diluted earnings per share were -$0.99.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q3 FY2026 | - | - | -$7.2M | -$0.99 |
| Q2 FY2026 | - | - | -$7.2M | -$2.58 |
| Q1 FY2026 | - | - | -$8.2M | -$4.35 |
| Q4 FY2025 | - | - | -$8.1M | - |
| Q3 FY2025 | - | - | -$6.1M | -$16.42 |
| Q2 FY2025 | - | - | -$6.3M | -$23.31 |
| Q1 FY2025 | - | - | -$5.8M | -$32.67 |
| Q4 FY2024 | - | - | -$1.2M | - |
Results filings
- Quarterly report 10-Q
- Quarterly report 10-Q
- Quarterly report 10-Q
- Annual report 10-K
When is BriaCell Therapeutics Corp.'s next earnings date?
BriaCell Therapeutics Corp. was expected to report around October 15, 2026; nothing is on file with the SEC yet.
Get an email when BCTX reports
Follow BCTX and we email you its next results the day they are filed, with the numbers explained.